2008 Senior Awards
David Avigan, M.D.
Beth Israel Deaconess Medical Center, Boston, MA
"Vaccination and T cell therapy Using DC/Myeloma fusions with Transplant"
Ralf Bargou, M.D.
University of Wurzburg, Wurzburg, Germany
"Overcoming drug resistance in MM: development of an in vivo mouse model"
Ruben Carrasco, M.D.
Dana-Farber Cancer Institute, Boston, MA
"Targeting Wnt Signaling in Myeloma Using Stabilized Alpha-Helices of BCL9"
Marta Chesi, Ph.D.
Mayo Clinic, Scottsdale, AZ
"Comparative oncogenomic to identify myeloma progression events"
Alfred Goldberg, Ph.D.
Harvard Medical School, Boston, MA
"Development of Novel Types of Proteasome Inhibitors that Regulate Substrate"
Lori Hazlehurst, Ph.D.
H. Lee Moffitt Cancer Center, Tampa, FL
"Beta 1 integrin inhibitory peptides: Novel agents for the treatment of MM"
Constantine Mitsiades, M.D., Ph.D.
Dana-Farber Cancer Center, Boston, MA
"Erastin analogs as anti-myeloma agentswth Factor for Treatment of Myeloma"
Shigeki Miyamoto, Ph.D.
University of Wisconsin, Madison, WI
"Targeting a third NF-KB pathway for anti-myeloma drug development"
Jetze Tepe, Ph.D.
Michigan State University, East Lansing, MI
"Phosphoproteomic analysis of NF-kappaB in MM"
Qing Yi, M.D., Ph.D.
M.D. Anderson Cancer Center, Houston, TX
"Anti-b2M monoclonal antibodies as therapeutic agent for myeloma"
Fenghuang Zhan, M.D., Ph.D.
University of Arkansas for Medical Sciences, Little Rock, AR
"RARa2 expression, a predictor for ATRA treatment in myeloma"